ArticleJACC. Case reports2025
Cardiac Involvement in a Patient With Aortic Aneurysm, Familial Thoracic-8.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Characterization of a New PRKG1 Mutation Associated With Thoracic Aortic Aneurysm and Dissection.JACC. Basic to translational science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAortic aneurysm, familial thoracic-8 (AAT-8) is a rare genetic aortopathy caused by mutations in PRKG1. Cardiac involvement has not been previously reported. CASE SUMMARY: We report the case of a young man who was diagnosed with Stanford type B aortic dissection, later diagnosed as AAT-8, at age 11 years. At age 24 years, he developed severe heart failure and was found to have diffuse coronary artery ectasia. An endomyocardial biopsy was nonspecific. Three months later, he experienced an ST-segment elevation myocardial infarction due to thrombotic occlusion within an ectatic coronary artery. After intervention, his left ventricular ejection fraction remained severely reduced, and he has been referred for advanced heart failure therapies. DISCUSSION: The severe cardiomyopathy and coronary ectasia seen in this case represent novel cardiac manifestations of AAT-8. The underlying PRKG1 gain-of-function mutation, known to affect smooth muscle cell relaxation, likely predisposed the patient to both vasculopathy and cardiomyocardiopathy. TAKE-HOME MESSAGE: Clinicians should be aware that AAT-8 can present with severe cardiomyopathy and coronary ectasia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.